"A world-wide prospective study of INC on prognosis and biomarkers in GBS"

A world-wide prospective study of INC on prognosis and biomarkers in GBS

Number of inclusions @ 3 March 2020

Publication success

We are excited to announce the acceptance/publication of three IGOS-related papers
  1. Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomized ISID study, Verboon, et al, Journal of Neurology, Neurosurgery, and Psychiatry
  2. Current treatment practice of Guillain-Barré syndrome, Verboon, et al, Neurology
  3. Diagnosis and management of Guillain–Barré syndrome in ten steps, Leonhard et al, Nature Reviews Neurology
More >>
More news

IGOS steering committee

  • Bart Jacobs, Erasmus MC Rotterdam Netherlands
  • Richard Hughes, Institute of Neurology, London, United Kingdom
  • David Cornblath, Johns Hopkins University, Baltimore, USA
  • Pieter van Doorn, Erasmus MC Rotterdam Netherlands
  • Ken Gorson, Tufts University School of Medicine, Boston, USA
  • Hans-Peter Hartung, Heinrich Heine University, Dusseldorf, Germany
  •  
  • Hugh Willison, University of Glasgow, United Kingdom
  • Susumu Kusunoki, Kinky University School of Medicine, Osaka, Japan